Larimar Therapeutics, Inc. (LRMR)

NASDAQ

$2.15

$-0.02

(-0.83%)

Pre-Market

Larimar Therapeutics, Inc. (LRMR) Live Price Chart

Last updated: ⁦2026-10-20 12:05:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Larimar Therapeutics, Inc. (LRMR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.15, with a market capitalization of $206.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.92 to $6.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$206.21M
Open	$2.16
Day's High	$25.87
Day's Low	$1.53
Previous Close	$2.12
Volume	50.00
Average Volume	1.31M
P/E Ratio	--
52-Week High	$6.42
52-Week Low	$1.92
Dividend Yield	--
Earnings Date	--

Larimar Therapeutics, Inc. (LRMR) Pre-Market Stock Price

Larimar Therapeutics, Inc. (LRMR) is trading at $2.15 in pre-market trading as of 2026-10-20 11:57:00, up 1.18% ($0.02) from the previous close of $2.12

Pre-market trading shows how investors are pricing LRMR before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Larimar Therapeutics, Inc. (LRMR) 7-Day Stock Price Change

Over the past seven days, Larimar Therapeutics, Inc. (LRMR) moved from $2.67 to $2.15, representing a decline of 19.66% ($0.52).

The stock traded between $1.92 and $2.74 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.25 million shares, up versus the previous seven-day period, indicating higher trading activity.

LRMR 52-Week Price Position

Position in Range: 5.1%

52W Low$1.92

52W High$6.42

LRMR is currently trading at $2.15, placing it 5.1% of the way from its 52-week low of $1.92 to its 52-week high of $6.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Larimar Therapeutics, Inc. (LRMR)?

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

Larimar Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	71
Exchange	NASDAQ
Company Website	https://www.larimartx.com

How to Buy Larimar Therapeutics, Inc. (LRMR) Stock on MEXC

Eligible investors can buy real shares of Larimar Therapeutics, Inc. (LRMR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LRMR and Place Your Order

Open the RealStocks trading page and search for LRMR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Larimar Therapeutics, Inc. (LRMR) stock price today?

Larimar Therapeutics, Inc. (LRMR) is currently trading at $ 2.15, up 1.18% ($0.02) from the previous close of $ 2.12. Intraday prices update in real time during regular trading hours.

2.Is LRMR stock going up or down today?

As of 2026-10-20 11:57:00, LRMR is trading at $ 2.15, up 1.18% ($0.02) from its previous close of $ 2.12. The stock has traded between $ 1.53 and $ 25.87 during today’s regular session. Past price movements do not guarantee future results.

3.What is LRMR pre-market price?

As of 2026-10-20 11:57:00, LRMR is trading at $ 2.15 in pre-market trading, up 1.18% ($0.02) from the previous close of $ 2.12. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LRMR after-hours price?

As of 2026-10-20 11:57:00, LRMR is trading at $ 2.15 in after-hours trading, up 1.60% ($0.03) from the regular-session close of $ 2.12. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LRMR stock trading now?

LRMR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LRMR sit relative to its 52-week high and low?

Over the past 52 weeks, LRMR has traded between a low of $ 1.92 and a high of $ 6.42. At $ 2.15, the stock is positioned 5.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Larimar Therapeutics, Inc. in?

Larimar Therapeutics, Inc. (LRMR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Larimar Therapeutics, Inc.'s market capitalization and where is it listed?

Larimar Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 206.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LRMR valued in terms of P/E ratio and EPS?

LRMR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.66. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Larimar Therapeutics, Inc. pay a dividend?

Larimar Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.